Valuation Metrics and Financial Health
Unihealth Hosp’s price-to-earnings (PE) ratio stands at 33.9, which, while elevated compared to many sectors, is relatively moderate within the healthcare industry. The price-to-book (P/B) value of 3.82 suggests that the market values the company at nearly four times its net asset value, reflecting investor confidence in its growth prospects. The enterprise value to EBITDA (EV/EBITDA) ratio of 13.3 further supports this moderate valuation, indicating the company is not excessively priced relative to its earnings before interest, taxes, depreciation, and amortisation.
Importantly, the PEG ratio of 0.94 is below 1, signalling that Unihealth Hosp’s price is reasonable relative to its earnings growth potential. This is a key indicator...
Read More





